UCLA Journal of Radiation Oncology SPRING 2024 - Flipbook - Page 43
UCLA RADIATION ONCOLOGY JOURNAL
41. N Scher, M Bollet, G Bouilhol, et al. Safety and efficacy of fiducial marker implantation for robotic stereotactic
body radiation therapy with fiducial tracking. Radiat Oncol, 14 (1) (2019), p. 167, 10.1186/s13014-019-1373-2
42. D Moore-Palhares, L Ho, L Lu, et al. Clinical implementation of magnetic resonance imaging simulation for
radiation oncology planning: 5 year experience. Radiat Oncol, 18 (1) (2023), p. 27, 10.1186/s13014-023-02209-4
43. M Lerner, J Medin, C Jamtheim Gustafsson, et al. Clinical validation of a commercially available deep
learning software for synthetic CT generation for brain. Radiation Oncology, 16 (1) (2021), 10.1186/s13014-02101794-6
44. E Palmér, A Karlsson, F Nordström, et al. Synthetic computed tomography data allows for accurate absorbed
dose calculations in a magnetic resonance imaging only workflow for head and neck radiotherapy. Phys Imaging
Radiat Oncol, 17 (2021), p. 36-42, 10.1016/j.phro.2020.12.007
45. SH Hsu, Z Han, JE Leeman, et al. Synthetic CT generation for MRI-guided adaptive radiotherapy in prostate
cancer. Front Oncol, 12 (2022), Article 969463, 10.3389/fonc.2022.969463
46. Centers for Medicare & Medicaid Services. Billing and coding guidelines for radiation oncology including.
intensity modulated radiation therapy (IMRT) . Accessed December 2, 2023.https://downloads.cms.gov/medicarecoverage-database/lcd_attachments/34652_13/L34652_RAD014_BCG.pdf
47. American Society for Radiation Oncology (ASTRO). Basics of coding. Accessed December 2, 2023. https://www
astro.org/Daily-Practice/Reimbursement/Practice-Management-Resources/Basics-of-Coding
48. Centers for Medicare & Medicaid Services. Radiation oncology model. Accessed March 29, 2023. https://
innovation.cms.gov/innovation-models/radiation-oncology-model
49. RF Palm, KG Eicher, AJ Sim, et al. Assessment of mri-linac economics under the ro-apm. J Clin Med, 10 (20)
(2021), p. 4706, 10.3390/jcm10204706
50. WA Hall, E Paulson, XA Li, et al. Magnetic resonance linear accelerator technology and adaptive radiation
therapy: An overview for clinicians. CA Cancer J Clin, 72 (1) (2022), 10.3322/caac.21707
51. C Hehakaya, JRN van der Voort van Zyp, BGL Vanneste, et al. Early health economic analysis of 1.5 T MRIguided radiotherapy for localized prostate cancer: Decision analytic modeling. Radiother Oncol, 161 (2021), pp.
74-82, 10.1016/j.radonc.2021.05.022
52. LED Schumacher, AD Pra, SE Hoffe, et al. Toxicity reduction required for MRI-guided radiotherapy to be costeffective in the treatment of localized prostate cancer. Brit J Radiol, 93 (1114) (2020), Article 20200028, 10.1259/
bjr.20200028
53. DA Shumway, KA Griffith, LJ Pierce, et al. Wide variation in the diffusion of a new technology: Practice-based
trends in intensity-modulated radiation therapy (IMRT) use in the state of michigan, with implications for IMRT
use nationally. J Oncol Pract, 11 (3) (2015), pp. e373-e379, 10.1200/JOP.2014.002568
54. A Eisbruch, J Harris, AS Garden, et al. Multi-institutional trial of accelerated hypofractionated intensitymodulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys, 76
(5) (2010), pp. 1333-1338, 10.1016/j.ijrobp.2009.04.011
55. CM Nutting, JP Morden, KJ Harrington, et al. Parotid-sparing intensity modulated versus conventional
radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial. Lancet
Oncol, 12 (2) (2011), pp. 127-136, 10.1016/S1470-2045(10)70290-4
56. PJ Parikh, P Lee, D Low, et al. Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for
patients with borderline or locally advanced pancreatic cancer: Primary endpoint outcomes of a prospective
phase II multi-center international trial. Int J Radiat Oncol Biol Phys, 114 (5) (2022), pp. 1062-1063, 10.1016/j.
ijrobp.2022.09.010
57. S Rudra, N Jiang, SA Rosenberg, et al. Using adaptive magnetic resonance image-guided radiation therapy for
treatment of inoperable pancreatic cancer. Cancer Med, 8 (5) (2019), pp. 2123-2132, 10.1002/cam4.2100
58. JE van Timmeren, M Chamberlain, J Krayenbuehl, et al. Treatment plan quality during online adaptive replanning. Radiat Oncol, 15 (1) (2020), p. 203, 10.1186/s13014-020-01641-0
59. EB Van Dieren, LGM Zwart, A Bhawanie, et al. Adaptive radiotherapy can be applied routinely, using an
artificial intelligence solution, to treat prostate cancer patients. Int J Radiat Oncol Biol Phys, 108 (3) (2020), pp.
E274-E275, 10.1016/j.ijrobp.2020.07.658
60. D Cusumano, L Boldrini, J Dhont, et al. Artificial Intelligence in magnetic resonance guided Radiotherapy:
Medical and physical considerations on state of art and future perspectives. Phys Med, 85 (2021), pp. 175-191,
10.1016/j.ejmp.2021.05.010
43